Compare AMRX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | FIZZ |
|---|---|---|
| Founded | 2002 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | FIZZ |
|---|---|---|
| Price | $13.06 | $33.90 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 4 | 1 |
| Target Price | $14.75 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.3M | 172.3K |
| Earning Date | 05-01-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 5.29 |
| EPS | 0.22 | ★ 1.53 |
| Revenue | N/A | ★ $1,201,354,000.00 |
| Revenue This Year | $4.48 | $0.14 |
| Revenue Next Year | $7.13 | $3.33 |
| P/E Ratio | $59.61 | ★ $22.35 |
| Revenue Growth | N/A | ★ 0.81 |
| 52 Week Low | $7.01 | $31.21 |
| 52 Week High | $15.42 | $47.88 |
| Indicator | AMRX | FIZZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 44.31 |
| Support Level | $12.50 | $33.64 |
| Resistance Level | $13.54 | $36.14 |
| Average True Range (ATR) | 0.33 | 0.86 |
| MACD | 0.15 | 0.09 |
| Stochastic Oscillator | 87.42 | 30.97 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).